Your browser doesn't support javascript.
loading
The prognostic value of RASGEF1A RNA expression and DNA methylation in cytogenetically normal acute myeloid leukemia.
He, Xue; Zhang, Weilong; Fu, Wei; Liu, Xiaoni; Yang, Ping; Wang, Jing; Zhu, Mingxia; Li, Shaoxiang; Zhang, Wei; Zhang, Xiuru; Dong, Gehong; Yan, Changjian; Zhao, Yali; Zeng, Zhiping; Jing, Hongmei.
Afiliação
  • He X; Department of Pathology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Zhang W; Department of Pathology, Capital Medical University, Beijing, China.
  • Fu W; Department of Pathology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Liu X; Department of Hematology, Lymphoma Research Center, Peking University Third Hospital, Beijing, China.
  • Yang P; Department of Pathology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Wang J; Department of Hematology, Lymphoma Research Center, Peking University Third Hospital, Beijing, China.
  • Zhu M; Department of Pathology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Li S; The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China.
  • Zhang W; Department of Hematology, Lymphoma Research Center, Peking University Third Hospital, Beijing, China.
  • Zhang X; Department of Hematology, Lymphoma Research Center, Peking University Third Hospital, Beijing, China.
  • Dong G; Department of Hematology, Lymphoma Research Center, Peking University Third Hospital, Beijing, China.
  • Yan C; Department of Pathology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Zhao Y; Department of Pathology, Capital Medical University, Beijing, China.
  • Zeng Z; Department of Pathology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Jing H; Department of Pathology, Capital Medical University, Beijing, China.
Cancer Biomark ; 36(2): 103-116, 2023.
Article em En | MEDLINE | ID: mdl-36404533

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article